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Normal physiologic functions of the cellular prion pro-
tein (PrPc) are still elusive. This GPI-anchored protein
exerts many functions, including roles in neuron prolif-
eration, neuroprotection or redox homeostasis. There
are, however, conﬂicting data concerning its role in
synaptic transmission. Although several studies report
that PrPc participates in NMDA-mediated neurotrans-
mission, parallel studies describe normal behavior of
PrPc-mutant mice. Abnormal axon connections have
been described in the dentate gyrus of the hippocampi
of PrPc-deﬁcient mice similar to those observed in
epilepsy. A study indicates increased susceptibility to
kainate (KA) in these mutant mice. We extend the ob-
servation of these studies by means of several histo-
logic and biochemical analyses of KA-treated mice.
PrPc-deﬁcient mice showed increased sensitivity to
KA-induced seizures in vivo and in vitro in organotypic
slices. In addition, we show that this sensitivity is cell-
speciﬁc because interference experiments to abolish
PrPc expression increased susceptibility to KA in PrPc-
expressing cells. We indicate a correlation of suscepti-
bility to KA in cells lacking PrPc with the differential
expression of GluR6 and GluR7 KA receptor subunits
using real-time RT-PCR methods. These results indicate
that PrPc exerts a neuroprotective role against KA-
induced neurotoxicity, probably by regulating the exp-
ression of KA receptor subunits. VC 2007 Wiley-Liss, Inc.
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The cellular prion protein (PrPc) is a glycosylphos-
phatidylinositol (GPI)-anchored cell surface protein pres-
ent in mammals, birds, and several invertebrates. PrPc,
encoded by the Prnp gene in mammals, is highly ex-
pressed by neurons and glial cells in the adult central
nervous system (CNS) (Kretzschmar et al., 1986; Moser
et al., 1995; Brown et al., 1997a; Fournier, 2001; Ford
et al., 2002; Moleres and Velayos, 2005). The abnormal
processing of PrPc gives rise to a proteinase-k resistant
isoform termed PrPsc, which is the etiologic agent
of several transmissible spongiform encephalopathies
(Prusiner, 1982). These encephalopathies are character-
ized by profound histologic changes, including extensive
neuronal death, reactive gliosis and neuroinﬂammation,
and extracellular accumulation of aggregated PrPsc in
infected brains (Prusiner, 1998a,b; Prusiner et al., 1998;
Aguzzi and Polymenidou, 2004).
Although many studies have examined the function
of PrPc, its physiologic role in healthy neurons remains
to be elucidated. PrPc was implicated initially in copper
homeostasis in healthy brain (Brown et al., 1997a;
Vassallo and Herms, 2003). Other studies have reported
PrPc to be involved in additional neural functions such
as neuronal plasticity (Maglio et al., 2004) and prolifera-
tion (Steele et al., 2006), or neurite outgrowth (Chen
et al., 2003; Santuccione et al., 2005). Interestingly,
recent studies point to a neuroprotective role of PrPc
(Chiarini et al., 2002; Chen et al., 2003). Indeed, PrPc
is overexpressed in ischemic brain and correlates with
neuroprotective effects (McLennan et al., 2004; Weise
et al., 2004). Moreover, Prnp 2/2 hippocampal cultures
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are more susceptible to cell death than Prnp þ/þ neurons
after serum removal (Kuwahara et al., 1999). Finally, PrPc
protects human primary neurons in culture against bax-
mediated apoptosis (Bounhar et al., 2001), thus
corroborating the role of this protein in neuroprotection
and cell survival.
The ﬁrst descriptions of mice lacking the Prnp gene
reported intrinsic resistance to prion infection (Bueler
et al., 1993) but also normal development and perform-
ance in most behavioral tests (Bueler et al., 1992). How-
ever, further detailed studies proposed that the phenotype
of Prnp 2/2 neurons is particularly sensitive to stress
(Brown et al., 1997b, 2002), which correlates with alter-
ations in sleep and circadian impairment in PrPc-deﬁ-
cient mice (Tobler et al., 1997, 1996).
Prnp 2/2 mice display mossy ﬁber collateral and
terminal sprouting in the hippocampus, similar to obser-
vations in epileptic patients (Colling et al., 1997). In
addition, PrPc-mutant mice show increased susceptibility
to and death after kainate (KA) injections compared to
wild-type animals (Walz et al., 1999). It has been
reported that glutamate treatment is less toxic than KA
in Prnp 2/2 neurons (Brown et al., 2002). These differ-
ences may be associated with differential expression of
glutamate/KA receptors or with afﬁnity variables. Little
data is available about these issues and a correlation has
been shown only recently between the increased long-
term potentiation (LTP) observed in the hippocampus of
Prnp 2/2 mice with the overexpression of mRNAs for
N-methyl-D-aspartate (NMDA) receptor subunits NR2A
and NR2B in Prnp 2/2 neurons (Maglio et al., 2004).
No detailed biochemical study of AMPA/KA receptor
expression or histologic description of susceptibility of
Prnp 2/2 mice to KA have been carried out. We
show, using several methods, the cell-speciﬁc susceptibil-
ity of hippocampal Prnp-deﬁcient neurons to KA in vivo
as well as in vitro in organotypic cultures. Indeed, loss-
of-function experiments in neuroblastoma cells
using siRNA against PrPc increased susceptibility to KA
in transfected cultures. Finally, we show that this suscep-
tibility correlates with the differential expression GluR6
and GluR7 KA receptors in Prnp-deﬁcient neurons.
MATERIALS AND METHODS
Animals
PrPc-deﬁcient mice (Prnp 2/2) were purchased from
EMMA (Monterotondo, Italy). Forty-four Prnp 2/2 adult
mice were used. In addition, 21 C57BL6J mice (Iffa Credo,
France) were also used. To avoid putative background-speciﬁc
differences between Prnp and wild-type mice, Prnp 2/2 mice
were crossed with C57BL6J mice from several generations
and the experiments were conducted using littermates derived
from heterozygous (Prnp þ/2) parents (50 littermates, 34 adult
mice and 16 newborn mice). Genotyping of Prnp 2/2 mice
was done using two PCR reactions, as described by Bueler
et al. (1993) (see also Gavin et al., 2005 for details). All exper-
imental procedures were carried out in accordance with the
guidelines of the Spanish Ministry of Science and Technology
following European standards.
KA Injections and Scoring of Seizure Severity
The C57BL6J strain is seizure-resistant in comparison to
other genetic backgrounds of mice (McKhann et al., 2003).
The Prnp 2/2 strain used in the present study was generated
on a C57BL6J background (Bueler et al., 1992). Thus, to
induce convulsive non-lethal seizures in C57BL6J mice, we
developed a progressive KA treatment by administering several
consecutive intraperitoneal (i.p.) injections of the glutamate
agonist KA (Sigma, Poole Dorset, UK) dissolved in 0.1 M
phosphate buffered saline (PBS) pH 7.4. A total of 10 Prnp þ/þ,
13 Prnp 2/2 mice, and 5 Prnp þ/2 were subjected to
KA experiments. Prnp þ/þ, Prnp þ/2, and wild-type
animals were processed in parallel. Animals were weighed and
i.p. injected with several pulses (four injections) of KA (8 mg/
kg b.w.) every 30–60 min for up to 4 hr. Injected animals
displayed forelimb clonus, rearing, and falling, or continuous
tonic clonic seizures and were analyzed during 7 hr after the
ﬁrst injection. Seizure intensity after KA injections was eval-
uated as described previously (Peng et al., 1997; Lee et al.,
2000). After the ﬁrst KA injections, the animals developed
profound hypoactivity and immobility (Grade I–II). After suc-
cessive injections, hyperactivity (Grade III) and scratching
(Grade IV) were often observed. Some animals (especially
Prnp 2/2 mice) progressed to a loss of balance control
(Grade V) and further chronic whole body convulsions (Grade
VI). The so-called ‘‘popcorn’’ bouncing activity was included
in Grade VI of the scale used in our study. After the behav-
ioral study, mice were kept in separate boxes until histologic
or biochemical study 48 hr after the treatment. Twelve hours
after KA-treatment, wild-type and Prnp þ/2 mice showed
normal behavior compared to Prnp 2/2. KA-treated Prnp 2/
2 mice displayed hypoactivity and immobility. This hypoac-
tivity was paralleled by relevant sensitivity of mice to external
stimuli (e.g., box handling). These low activity symptoms
were observed in Prnp 2/2 mice until processing.
Organotypic Slice Cultures of Hippocampus
Hippocampal slice cultures (n ¼ 50) were prepared from
P0 (day of birth), P1 Prnp þ/þ (n ¼ 10), or mutant mouse
pups (n¼ 10), as described previously (Del Rio et al., 1997).
Animals were anaesthetized, brains were removed aseptically
from the skull, and hippocampi were dissected. Horizontal
slices (325–350 lm thick) containing the hippocampus were
then prepared using a McIlwain tissue chopper (Mickle Labo-
ratory, Surrey, UK). Sections were maintained and selected in
Minimum Essential Medium (MEM) supplemented with
glutamine (2 mM) (MEM dissecting salt solution) for 45 min
at 48C. Selected slices were then cultured using the membrane
interface method (Stoppini et al., 1991). Slices were placed on
30-mm diameter sterile membranes (Millicell-CM, Millipore,
Billerica, MA) and transferred to six-well tissue culture plates
(Nunc, Roskilde, Denmark). Cultures were incubated with
1.2 ml of culture medium (50% MEM; 25% horse serum;
25% HBSS) containing 2 mM glutamine and 0.04% NaHCO3
adjusted to pH 7.3. The membrane cultures were maintained
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in a humidiﬁed incubator at 378C in a 5% CO2 atmosphere.
The medium was changed every 2 days. All culture reagents
were purchased from Invitrogen-Life Technologies (Merel-
beke, Belgium).
Pharmacologic Treatments of Slice Cultures
Neuronal death after glutamate or KA treatment in orga-
notypic slice cultures was monitored by propidium iodide (PI)
uptake (Del Rio et al., 1997; Noraberg et al., 2005). Hippo-
campal slice cultures were deprived of serum for 3 hr and
exposed to 50 lM of KA for 2 hr. After treatment, cultures
were rinsed twice in KA-free culture media. The next day,
slices were incubated for 2 hr with 1 lg/ml of PI dissolved in
culture media. PI-treated slices were ﬁxed with 2% parafor-
maldehyde dissolved in 0.1 M PBS (pH ¼ 7.3) for 1 hr. After
rinsing in 0.1 M PBS, cultures were mounted in Mowiol,
examined, and photo documented in a confocal microscope.
To determine the max/min PI ﬂuorescence for quantiﬁcation,
parallel time-aged cultures were treated with 50 mM gluta-
mate for 2 hr or alternatively with 0.1 M PBS, and processed
as above. Total ﬂuorescence in the pyramidal layer of the
hippocampus was measured in a 500-lm segment of the layer
in the CA1-3 regions using Quantity One Imaging and Analysis
software (BioRad, Hertfordshire, UK). In parallel cultures, the
non-competitive NMDA receptor antagonist (þ)-5-methyl-
10,11-dihydro-5H-dibenzo[a,b]-cyclohepten-5,10-imine (MK-
801; Sigma, St. Louis, MO) (Wong et al., 1986) was added
30 min before KA-treatment at 10 and 30 lM to Prnp 2/2
cultures to address the participation of NMDA receptors in
the KA-induced cell death.
Histologic Methods
Two days after KA-treatment, mice (control and KA-
treated) were perfused with phosphate buffered 4% parafor-
maldehyde pH 7.3, postﬁxed overnight in the same ﬁxative,
and cryoprotected in 30% sucrose. Coronal sections (30-lm
thick) were obtained in a freezing microtome. Free-ﬂoating
sections from different mice were processed in parallel. Free-
ﬂoating sections were rinsed in 0.1 M PBS and endogenous
peroxidases were blocked by incubation in 3% H2O2 and 10%
methanol dissolved in 0.1 M PBS. After extensive rinsing,
sections were incubated in 0.1. M PBS containing 0.2% gela-
tin, 10% normal serum, 0.2% glycine, and 0.2% Triton-X 100
for 1 hr at room temperature. Sections were then incubated
overnight at 48C with the distinct primary antibodies, using
the following dilutions: a-fos (1:5,000, Santa Cruz Biotechnol-
ogy, Santa Cruz, CA); a-GluR1, (1:1,000, Chemicon, Teme-
cula, CA); a-GluR2/3, (1:500, Chemicon); a-GluR4, (1:250,
Chemicon); a-GluR6-7, (1:250, Chemicon); a-ERK1-2
pthreonine-202/ptyrosine-204, a-p38 pthreonine180/ptyro-
sine182 or JNK-pthreonine-183/ptyrosine-185 (all 1:200, Cell
Signalling, Beverly, MA); and glial ﬁbrillary acidic protein (a-
GFAP, 1:200, Dakopatts, Denmark). Thereafter, sections were
incubated with secondary biotinylated antibodies and strepta-
vidin–horseradish peroxidase complex (Vector Labs, Burlin-
game, CA), following the manufacturer’s instructions (Vector
Labs) Sections were developed with 0.025% diaminobenzidine
and 0.003% hydrogen peroxide, mounted onto slides, dehy-
drated, and coverslipped with Eukitt (Merck, Darmstadt, Ger-
many). Selected sections were processed for double immuno-
ﬂuorescence (e.g., pERK1-2 þ GFAP) using Alexa-Fluor
488- and Alexa-Fluor 568-tagged secondary antibodies (Mo-
lecular Probes, Eugene, OR).
Fluoro-Jade B Staining of Dying Neurons
in Brain Sections
Coronal brain sections were obtained as above. There-
after, sections were rinsed for 2 hr in Tris 0.1 M, pH 7.4,
mounted, and air-dried at room temperature overnight. The
next day, sections were pre-treated for 3 min in absolute
alcohol, followed by 1 min in 70% ethanol and 1 min in dis-
tilled water. They were then oxidized in a solution of 0.06%
KMnO4 for 15 min. After three rinses of 1 min each with
distilled water, the sections were incubated for 30 min in a
solution of 0.001% Fluoro-Jade B (Chemicon) containing
0.01% of DAPI in 0.1% acetic acid. The slides were rinsed in
deionized water for 3 min each, dried overnight, cleared in
xylene, and coverslipped with Eukitt. Sections were examined
using an epiﬂuorescent microscope with blue-violet excitation
light set at 450 nm and 350 nm, respectively. Fluoro-Jade
B-stained cells emit a typical green color with excitation peak
at 480 nm and emission peak around 525 nm.
Cell Culture and Small Interfering
RNA (siRNA) Transfection
We assessed the excitotoxic effect of 200 lM KA on
Neuro2A (N2A) cells with low levels of PrPc expression by
using siRNA transfection. PrPc siRNA used for prion silenc-
ing and the scramble siRNA sequence used as a control were
obtained from (Daude et al., 2003) and were synthesized by
Darmacon (Lafayette, LA). N2A cells were grown at 378C,
5.5% CO2, in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
supplemented with 4.5 g/l glucose, 10% FBS, and antibiotics.
For siRNA transfection, cells were plated at 1 3 105 cells/
well in a 24-well plate and transfected the next day using Lip-
ofectamine 2000, following the manufacturer’s instructions
(Invitrogen-Life Technologies). Brieﬂy, 1 ll Lipofectamine
2000 was mixed with siRNAs (400 nM) in 50 ll of Opti-
MEM medium and after 30 min at room temperature it was
added to N2A cells for 4 hr. The decrease in PrPc expression
after treatment was checked by Western blot analysis. KA-
treatments were carried out on serum-deprived cells 48 hr af-
ter siRNA transfection. Afterward, KA-treated cells were
incubated with 1 lg/ml PI for 1 hr, then ﬁxed in 1% parafor-
maldehyde in 0.1 M PBS and counterstained with DAPI (1
lM) to corroborate equal cell densities. For quantiﬁcation, the
number of PI-labeled cells was counted in a 500-lm2 square
using a 403 oil immersion objective. In parallel experiments,
total mRNA was obtained from siRNA (Prnp and scrambled)
treated cultures and processed to determine the expression
level of KA receptor subunits by real-time RT-PCR.
Semi-Quantitative RT-PCR of AMPA/KA Receptors
Two micrograms of total RNA obtained from Prnp 2/2
and wild-type mice through puriﬁcation with Trizol (Invi-
trogen-Life Technologies) were retrotranscribed using AMV
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reverse transcriptase (New England Biolabs, Herts, UK). Both
steps were carried out following the manufacturer’s instruc-
tions, except that we used our antisense oligonucleotides for
reverse transcription (instead of olgo-dT). Three micrograms
of cDNA (corresponding to 120 of the total RNA retrotran-
scribed) were ampliﬁed with Taq polymerase (Amersham
Biosciences, Buckinghamshire, UK) in a mixture containing
dNTPs, Taq buffer, 1.25 mM MgCl2 and oligonucleotides to
a ﬁnal volume of 25 ll. The oligonucleotide sequences were
the same as in the study by Paarmann et al. (2000) in all cases,
except for glyceraldehyde-3-phosphate dehydrogenase gapdh
cDNA ampliﬁcation, the sequences of which were the same
as in the study by Burgaya and Girault (1996). A total of
7.4 lCi of 33P-dATP (Amersham Biosciences) was added to
each reaction as a tracer.
Each ampliﬁcation cycle consisted of 30 sec denaturation
at 948C, 30 sec of annealing at 608C and 35 sec elongation at
728C. A single, previous step of 2 min at 948C and a ﬁnal
elongation of 7 min at 728C were used for optimal resolution.
Quantitative ampliﬁcation and ﬁnest viewing of the radiola-
beled bands was achieved after 15 cycles for the multi-copy
gene gapdh, and 20 or 25 cycles for the glutamate receptor
subunit cDNAs. Five microliters of 63 loading buffer (30%
glycerol-bromophenol blue) was added to the mixture before
PAGE electrophoresis in 4% acrylamide/bis-acrylamide gels,
run in 13 TAE buffer. Gels were ﬁxed for 30 min in 7%
methanol–5% acetic acid and vacuum-dried over Whatman
paper for 2 hr at 608C before exposure to sensitive plates for
1–18 hr, and analyzed in a Typhoon 8600 scanner (Molecular
Dynamics, Sunnyvale, CA) using ImageQuant software (Mo-
lecular Dynamics).
Real-Time PCR
Quantitative PCR of was carried out using an ABI
PRISM 7700 sequence detection system equipment and
power Sybr green master mix (Applied Biosystems). Reaction
volumes of 12.5 ll were used with 0.5 lM primers. Speciﬁc
primers were taken from a database (http://pga.mgh.harvard.
edu/primerbank/) based on the published sequences of mouse
gapdh (NM_008084) (primers: forward, 50-AGGTCGGTGT-
GAACGGATTTG-30; reverse, 50-TGTAGACCATGTAGT-
TGAGGTCA-30) as referenced together with glutamate recep-
tors GluR6, AF245444 and GluR7, D10054 (GluR6, primers:
forward, 50-ATCGGATATTCGCAAGGAACC-30; reverse,
50-CCATAGGGCCAGATTCCACA-30 and GluR7, primers:
forward, 50-AGGTCCTAATGTCACTGACTCTC-30; reverse,
50-GCCATAAAGGGTCCTATCAGAC-30). Ampliﬁcation
conditions consisted of 2 sec denaturation at 958C, 15 sec of
annealing at 608C, and 1 min elongation at 608C for 40
cycles. The results were normalized by the expression levels of
the housekeeping gene, gapdh, which was quantiﬁed simulta-
neously with the target gene. We added 2 ll of the serially
diluted cDNA prepared from tissue to this mixture. A melting
point analysis was carried out to improve the sensitivity and
speciﬁcity of ampliﬁcation reactions detected with the Sybr
Green I dye. Data were analyzed by SDS 1.9.1 Software
(Applied Biosystems) following the 22DDCT method of
Applied Biosystems published by Livak and Schmitgen (2001).
Western Blotting Techniques
Tissue samples from the hippocampi of KA-treated mice
were homogenized (10% w/v) in ice-cold Tris-saline buffer
(50 mM Tris-HCl, 150 mM NaCl, pH 7.4) containing 0.5%
(w/v) Triton X-100, 0.5% (w/v) Nonidet P-40 (Igepal;
Sigma), and 13 cocktail of protease and phosphatase inhibitors,
using a motor-driven glass-Teﬂon homogenizer in ice. After
protein quantiﬁcation, tissue extracts (20 lg) were boiled in
Laemmli sample buffer at 1008C for 5 min, followed by
6–10% SDS-PAGE electrophoresis, electro transferred to
nitrocellulose membranes for 6 hr at 48C and processed for
immunoblotting using primary antibodies and the ECL-plus
kit (Amersham-Pharmacia Biotech). In our experiments, each
nitrocellulose membrane was used for detecting both phos-
phorylated and total kinase levels.
RESULTS
KA Sensitivity, Seizure Behavior, and Mortality
in Prnp 2/2 and Wild-Type Mice
The thresholds for onset and seizure behavior
in response to identical intraperitoneal KA injections dif-
fered greatly daggers, between Prnp 2/2, heterozygote,
and wild-type mice (daggers, Table I). Two Prnp 2/2
mice died whereas only one wild-type mouse died dur-
ing the experiments. Only two wild-type mice and no
heterozygote mice showed small (Grade III, hyperactiv-
ity) seizures after KA injection. In contrast, PrPc-deﬁ-
cient mice showed an increased number of seizures
(ranking from 13–19) with profound seizure impact
behavior (Grade V–VII). In addition, they maintained
Grade V–VI seizure for 3–6 hr whereas wild-type and
heterozygote mice displayed only grade III seizure for 3
hr. These data corroborate the results of Walz et al.
(1999) reviewed in Walz et al. (2002), and indicate
particular sensitivity of Prnp 2/2 mice to KA. Walz
et al. (1999) reported that 50% of prion mutant mice
showed repetitive seizures whereas no wild-type exhib-
ited observable seizures. In addition, our experiments
extend their observations to heterozygote mice, which
displayed similar behavior to that of wild-type animals.
After 7–8 hr, wild-type and heterozygote mice showed
normal behavior and the symptoms of Prnp 2/2 KA-
treated mice decreased gradually to a level of hypoactiv-
ity and immobility that was corroborated 12 hr after
treatment. This hypoactivity was maintained until the
histologic or biochemical processing of the mice.
Increased Seizure-Related Histopathology
in Prnp 2/2 Mice
To determine whether the severity of seizure
observed in Prnp 2/2 correlates with the pattern of
neuronal loss and reactive glial changes after KA injec-
tion as described in the literature, we carried out several
histochemical and immunohistochemical analyses (Figs.
1–3).
Sections from adult animals were labeled with Flu-
oro-Jade B stain, a marker for neuronal degeneration
(Schmued and Hopkins, 2000) (Fig. 1). Two days after
2744 Rangel et al.
Journal of Neuroscience Research DOI 10.1002/jnr
the last KA injection, Prnp 2/2 mice displayed numer-
ous cells with Fluoro-Jade B ﬂuorescence in the hippo-
campus, amygdala, and piriform cortex. In the hippo-
campus, numerous labeled cells were located in the
pyramidal layer of the CA1 and CA3 regions (Fig.
1A,B,E–G). In contrast, heterozygote and wild-type
C57BL6J mice displayed no ﬂuorescence in cells in these
regions (Fig. 1C,D,H–J). Fluorescence labeling in py-
ramidal cells extended from the neuronal perikaryon to
apical dendrites often displaying disrupted or condensed
chromatin after DAPI counterstaining (Fig. 1E–G).
In addition, increased c-fos immunoreactivity in
the same regions as above was observed in KA-treated
Prnp 2/2 in contrast to controls. Similar c-fos immu-
noreactivity distribution after KA injections was also
reported by Popovici et al. (1990) in KA-treated rats.
We observed particularly marked immunoreactivity in
Prnp 2/2 sections in the pyramidal layer of the CA1-3
(Fig. 2). Numerous nuclei were labeled in Prnp 2/2
mice in contrast to controls, where only a diffuse label-
ing in pyramidal neurons was observed (Fig. 2A–D).
Moreover, it is well known that the activation of glial
cells begins 2–3 days after KA treatment (Jorgensen
et al., 1993). Indeed, abundant GFAP-positive cells dis-
playing hypertrophy and thick processes were observed
in the neurodegenerative areas of the hippocampus in
Prnp 2/2 mice in contrast to wild-type mice (Fig.
2E,F). The present results indicate that KA-induced sei-
zure in prion mutant mice correlates with the histologic
descriptions of cell death and reactive gliosis in the hip-
pocampal region.
Increased Activation of Extracellular-Related
Kinases (ERK 1-2), P38 Stress-Associated Kinase,
and c-jun N-Terminal Kinase in the Hippocampi
of KA-Treated Prnp 2/2 Mice
Protein kinase-mediated signalling cascades consti-
tute the major route by which neurons and glial cells
respond to their extracellular environment. Mitogenic
or stress stimulation of the ERK1-2 pathway modulates
the activity of many transcription factors, leading to bio-
logic responses such as proliferation and differentiation
(Volmat and Pouyssegur, 2001). In addition, the p38/
SAPK2 pathways are activated strongly by stress stimuli
(Irving and Bamford, 2002). In addition, c-jun N-termi-
nal kinase (JNK) activation has also been associated with
cell death. There is a growing body of evidence showing
that these kinase signalling pathways are activated by a
variety of injury stimuli including focal cerebral ischemia
(Irving and Bamford, 2002) or glutamate/KA excitotox-
icity (Mao et al., 2004). In our experiments, KA-treated
Prnp2/2 mice displayed relevant activation of both
ERK1-2 and P38 kinases in Western blot of hippocam-
pal extracts compared to KA-treated controls (Fig. 3A).
Densitometric quantiﬁcation showed a 2.4-fold increase
in ERK1-2 activation and a 1.8-fold activation of P38
in Prnp 2/2 mice (Fig. 3B). Histologic correlation
using double immunoﬂuorescence showed that cells in
prion mutant mice expressing activated ERK1-2 after
KA-injection corresponded to reactive astroglia (GFAP-
positive) (Fig. 3C, D,G,L–N). In addition, pP38-immu-
noreacted sections of KA-treated Prnp 2/2 mice
showed a relevant increase in the labeling of mossy
ﬁbre projections, a decrease in neuronal pP38 labeling
in pyramidal neurons, and increased P38 in reactive
astrocytes compared to KA-treated controls (Fig. 3E,F,
H,I), which showed similar labeling to that detected in
untreated mice. In addition, pJNK staining was relevant
after KA-treatment in mossy ﬁbers (not shown) and py-
ramidal cells of CA1-3 in Prnp 2/2 mice compared to
controls (Fig. 3J,K). These results corroborate the notion
that the sensitivity of Prnp 2/2 mice to KA-induced
seizure correlates with the increased activation of
ERK1-2, P38 in glial cells and JNK in neurons of brain
regions susceptible of the lethal effects of the status epi-
lepticus.
TABLE I. Effects of KA-Induced Status Epilepticus and Death on Prnp 2/2, Heterozygotes and
Wild-Type Mice
Genotype Onset (min) No. of seizures Behavioral stages Prioritary stage (min)
Prnp 2/2 40 14 I–VI V–VI (6:20 hr)
Prnp 2/2 118 13 I–VI V–VI (5 hr)
Prnp 2/2 103 19 I–VI V–VI (6 hr)
Prnp 2/2 120 15 I–VI V–VI (4 hr)
Prnp 2/2 100 13 I–VI V–VI (5 hr)
Prnp 2/2 13 Continue I–VII {
Prnp 2/2 27 Continue I–VII {
Prnp 2/2 160 15 I–VI V–VI (3 hr)
Prnp þ/2 300 1 I–II III (3 hr)
Prnp þ/2 0 0 I–III III (5 hr)
Prnp þ/2 0 0 I–III III (3 hr)
Prnp þ/þ 61 1 I–VI III–IV (3 hr)
Prnp þ/þ 0 0 I–III III (5 hr)
Prnp þ/þ 31 Continue I–VII {
Prnp þ/þ 45 1 I–VII III (2 hr)
Prnp þ/þ 300 1 I–VI III (5 hr)
Prnp þ/þ 0 0 I–III III (6 hr)
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KA-Induced Seizure Responses in the Hippocampi
of Prnp 2/2 Mice Are Cell-Speciﬁc
Hippocampal damage induced by administration of
KA may be triggered not only by direct effect of this
compound on pyramidal neurons, but also through the
hyperactivity of the excitatory afferent pathway, i.e., the
entorhino-hippocampal (EH) connection (Sperk, 1994).
To ascertain whether neurotoxic differences are cell-spe-
ciﬁc or related to increased excitability of the activated
EH connection, we developed a parallel study in isolated
Fig. 1. Low power photomicrographs illustrating the pattern of
Fluoro-Jade B labeling (B,C,F,G,I,J) and DAPI counterstaining
(A,C,E,H) in the hippocampi of PrPc-deﬁcient (A,B,E–G) and con-
trol (C,D,H–J) mice after treatment with KA. Fluoro-Jade B labeled
cells were also observed in Prnp 2/2 mice especially in the CA1-3
region (B). Higher magniﬁcation shows that Fluoro-Jade B labels the
perikaryon and the apical dendrites of dying pyramidal cells (F). Cells
labeled with Fluoro Jade-B displayed condensed chromatin, as ascer-
tained by DAPI staining (E,G). Scale bars: (A,C) 500 lm pertains to
(B) and (D) respectively; (E,H), 100 lm pertains to (F,G) and (I,J)
respectively. Abbreviations: CA1-3, hippocampal ﬁelds; DG, dentate
gyrus; GL, granular layer; H, hilus; ML, molecular layer; SLM;
stratum lacunosum-moleculare; SO, stratum oriens; SP, stratum pyra-
midale, SR, stratum radiatum.
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hippocampi in organotypic slice cultures (Fig. 4). Prnp
2/2 and wild-type hippocampal slices were treated with
KA, 0.1 M PBS, or glutamate. The levels of PI uptake
were then measured in the pyramidal layer of the hippo-
campus (Fig. 4A–D). Prnp 2/2 slices showed a 2.6-fold
increase in PI-labeled cells compared to controls, the ﬂu-
orescence levels of glutamate and PBS being considered
the maximum and minimum levels for quantiﬁcation,
respectively (Fig. 4E). These data suggest that the
increased cell death observed in the hippocampal cells
corresponds to cell-speciﬁc differences in the response to
KA treatment not to increased or modiﬁed extra-hippo-
campal afferent stimulation. In a parallel experiment we
explored the participation of NMDA receptors in the
KA-induced cell death in Prnp 2/2 slices by using sev-
eral concentrations of the non-competitive antagonist
MK-801. Indeed, MK-801-treated cultures displayed a
signiﬁcant reduction of 15% (10 lM MK-801) and 40%
(30 lM of MK-801) of cell death in Prnp 2/2 slices af-
ter KA-treatment. These observations indicate the partic-
ipation of NMDA receptors in the KA-induced cell
death in Prnp 2/2 mice organotypic cultures.
Silencing of the Prnp Gene Induces KA-Dependent
Cell Death in Neuroblastoma Cells
We explored whether the speciﬁc silencing of the
Prnp gene induces sensitivity to KA in normal PrPc-
expressing cells. First, we incubated N2A cells with siRNA
plus a plasmid encoding eGFP (pcDNA3-eGFP) to explore
transfection efﬁciency using Lipofectamine 2000 (Fig. 5).
Microscopic observation showed that 70–80% of N2A cells
were transfected (Fig. 5). The decrease in PrPc expression
in siRNA (Prnp)-transfected cultures was later corrobo-
Fig. 2. A,B: Low power view of the hippocampal region illustrating
the distribution of c-fos immunoreactivity in the hippocampi of
PrPc-deﬁcient and control mice after intraperitoneal KA injections.
C,D: are a higher magniﬁcation of the squares shown in (A,B)
respectively. PrPc-deﬁcient hippocampi showed increased c-fos nu-
clear staining in pyramidal neurons (arrows in C). E,F: Photomicro-
graphs of the CA1 showing the pattern of GFAP immunostaining in
mutant mice (E) and control (F) after KA treatment. GFAP immuno-
staining strongly increased in the CA1. Scale bars: (A), 500 lm
pertains to (B); (C,E), 100 lm pertains to (D) and (F) respectively.
Abbreviations: CA1-3, hippocampal ﬁelds; DG, dentate gyrus; GL,
granular layer; H, hilus; ML, molecular layer; SLM; stratum lacuno-
sum-moleculare; SO, stratum oriens; SP, stratum pyramidale, SR,
stratum radiatum. [Color ﬁgure can be viewed in the online issue,
which is available at www.interscience.wiley.com.]
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Figure 3.
rated by Western blot (Fig. 5B). Furthermore, siR-
NA(Prnp)-, siRNA(scrambled)-, and Lipofectamine-trans-
fected N2A cells were treated with 200 lM of KA and fur-
ther incubated with PI (Fig. 5C–G). We observed a 4.8-
fold increase in the number of PI-labeled cells between
siRNA(Prnp)- and siRNA(scrambled) cells treated with
KA (Fig. 5C–G). These data indicate that the speciﬁc
silencing of PrPc increased sensitivity to KA in cultured
N2A cells, which supports the notion of a protective role of
PrPc.
Enhanced Susceptibility to KA-Induced Seizures
in PrPc-Deﬁcient Mice Correlates With
Differential Expression of GluR6-7 KA Receptor
Subunits in the Hippocampus
Ionotropic glutamatergic neurotransmission in the
CNS is mediated by NMDA and AMPA/KA receptors.
Prnp 2/2 mice present a diminished hyperlocomotor
response to MK-801 treatment compared to wild-type
animals, indicating that lack of PrPc leads to a functional
alteration of the glutamatergic system mediated by
NMDA receptors (Coitinho et al., 2002). In addition,
mutant mice show increased expression of NMDA re-
ceptor subunits NR2A and NR2B (Maglio et al., 2004).
However, literature provides no data concerning differ-
ential expression of AMPA/KA receptors in PrPc-deﬁ-
cient mice. We explored whether the sensitivity of prion
mutant mice to KA-induced seizure observed in our
experiments correlates with differential expression of
AMPA/KA receptor subunits in hippocampal neurons
(Fig. 6). First, coronal sections from mutant and control
mice were histologically processed to ascertain putative
differences in the pattern of expression of AMPA/KA
receptor subunits in the hippocampal formation. No rel-
evant differences were observed in the immunocyto-
chemical distribution pattern of the diverse AMPA/KA
receptor subunits in the hippocampi of mutant mice
compared to controls (not shown). Furthermore, to bet-
ter determine putative differences in subunit expression,
we carried out a radioactive semi-quantitative RT-PCR
study (Fig. 6A,B). We conﬁrmed that GluR1, GluR2,
GluR3, GluR4, and GluR5, as well as KA1 and KA2
mRNA levels in Prnp 2/2 mice remained similar to
wild-type hippocampus (Fig. 6B). However, GluR6 and
GluR7 mRNA levels were statistically increased in Prnp
2/2 mice compared to controls (Fig. 6A,B). This was
corroborated using Sybr green real-time RT-PCR (Fig.
6C–E) and statistical analysis. Gel electrophoresis and
melting point analysis were carried out to determine the
speciﬁcity of the ampliﬁed products (Fig. 6C,D). Quan-
tiﬁcation of the data showed a 2.33-fold increase and a
2.06-fold increase in the mRNA levels of GluR6 and
GluR7, respectively in Prnp 2/2 compared to wild-
type (Fig. 6E). These data indicate the increased expres-
sion of GluR6 and GluR7 KA receptor subunits in the
hippocampi of prion mutant mice, and suggest their par-
ticipation in the increased susceptibility to KA in these
animals. The presence of GluR6-7 KA-receptor subunits
in susceptible cells (hippocampal pyramidal cells) was
corroborated by immunohistochemistry in Prnp 2/2
mice (Fig. 6F). Last, we determined that neuroblastoma
cells treated with siRNA-Prnp showed increased GluR6
and GluR7 mRNA (Fig. 6G). The present data point to
a putative relation between PrPc and GluR6 and GluR7
expression, similar to the relation reported previously for
some NMDA receptor subunits (Maglio et al., 2004)
DISCUSSION
In recent years considerable research has addressed
the functions of PrPc (Martins et al., 2002; Sakudo
et al., 2006). Emerging data indicate that PrPc is crucial
in neuroprotection. This GPI-anchored protein protects
neurons against oxidative stress (Brown et al., 2001) or
bax-mediated apoptosis (Bounhar et al., 2001), probably
through its interaction with the stress-inducible protein
1 and activation of the PKA/cAMP signalling pathway
(Chiarini et al., 2002; Zanata et al., 2002). In addition,
recent studies also report parallel functions for PrPc. For
example, this protein promotes neuritogenesis by bind-
ing to laminin (Graner et al., 2000) or neural cell adhe-
sion molecule (NCAM) (Santuccione et al., 2005). With
respect to synaptic transmission, although mutant mice
were initially described without clear behavioral deﬁcits
(Bueler et al., 1992), further studies proposed the
involvement of PrPc in normal synaptic function because
Prnp 2/2 mice displayed impaired LTP (Collinge et al.,
1994). In addition, disrupted Ca2þ-activated Kþ currents
(Colling et al., 1996) and axon abnormalities have been
Fig. 3. A: Immunoblot of pERK1-2, ERK, pP38 and P38 in the
hippocampi of PrPc-mutant mice and control after KA-induced
seizure. Samples (50 lg) from hippocampi of the ages indicated were
analyzed. The molecular weight standards are shown on the right.
B: Histogram illustrating the densitometric analysis of the immuno-
blots shown in (A). Quantitative results from three independent
experiments are illustrated. Values are represented as mean 6 SD.
*Statistical differences between columns (P < 0.05; ANOVA) C–F:
Low power photomicrograph of the hippocampus showing the dis-
tribution of pERK1-2 (C,D) and pP38 (E,F) in Prnp 2/2 and con-
trol mice 72 hr after KA administration. Note the overall increase in
both activated kinases in the CA1-3 of the hippocampus and espe-
cially the increase in mossy ﬁbre labeling in PrPc-deﬁcient mice.
G–K: High magniﬁcation of the CA1 immunostained against
pERK1-2 (G), pP38 (H,I), and pJNK (J,K). Note the increase in
pERK1-2 and pP38 in reactive astroglia in Prnp 2/2 mice. In con-
trast, neuronal labeling of P38 decreased in the pyramidal layer,
whereas pJNK increased after treatment with KA. L–N: Examples of
double-labeled astrocytes (GFAP þ pERK1-2) (arrows) in the CA1
of Prnp 2/2 mice 72 hr after the ﬁnal KA injection. Scale bars:
(C,E), 500 lm pertains to (D) and (F), respectively; (G,J), 100 lm
pertains to (H,I) and (K), respectively; (L), 100 lm pertains to
(M,N). Abbreviations: CA1-3, hippocampal ﬁelds; DG, dentate gyrus;
GL, granular layer; H, hilus; ML, molecular layer; SLM; stratum
lacunosum-moleculare; SO, stratum oriens; SP, stratum pyramidale,
SR, stratum radiatum.
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reported in mutant mice (Colling et al., 1997). However,
these data were controversial because normal neuronal
excitability and synaptic transmission was described in
the hippocampus of Prnp 2/2 mice (Lledo et al., 1996).
Despite these discrepancies, it was shown recently that
PrPc-deﬁcient mice display facilitated glutamatergic trans-
mission with a lower threshold for generating LTP com-
pared to wild-type animals and paralleled by an increased
expression of the NMDA receptor subunits NR2A and
NR2B in the hippocampi of mutant mice (Maglio et al.,
2004). In addition, the same authors showed recently
increased LTP in older mutant mice compared to con-
trols (Maglio et al., 2006). These latter data indicate that
PrPc is involved in glutamatergic neurotransmission and
neuron homeostasis. In this regard, Walz et al. (1999)
described increased sensitivity to KA-mediated seizures in
PrPc-deﬁcient mice, which was further corroborated in
vitro in cell cultures (Brown et al., 2002). To date, how-
Fig. 4. A–D: Fluorescence images of organotypic hippocampal slice
cultures from PrPc-deﬁcient (A–C) and wild-type (D) mice incubated
with 50 mM glutamate (A), PBS 100 mM (B) or 50 lM KA (1 lg/
ml) (C,D) and incubated with propidium iodide (PI). Note
the relevant PI-incorporation in dying cells in Prnp 2/2 cultures
compared to controls E: Histogram illustrating quantitative results of
(A–D). F: Fluorescence images of hippocampal organotypic slice cul-
ture treated with 10 lM MK-801 and 50 lM KA. Note the presence
of PI-labeled cells. G: Histogram illustrating quantitative results of the
MK-801 experiments. Note the decrease in the number of PI-
labeled cells specially with 30 lM MK-801. Histograms in (E) and (G)
represent the mean 6 SD of three independent experiments. *Statisti-
cal differences between columns (P < 0.05; ANOVA). Scale bars: (A),
200 lm pertains to (B–D,F). Abbreviations: CA1-3, hippocampal ﬁelds;
DG, dentate gyrus; GL, granular layer; H, hilus; ML, molecular layer;
SLM; stratum lacunosum-moleculare; SO, stratum oriens; SP, stratum
pyramidale, SR, stratum radiatum. [Color ﬁgure can be viewed in the
online issue, which is available at www.interscience.wiley.com.]
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Fig. 5. A: Example of double transfected N2A
cells with siRNA(Prnp) and eGFP- expressing
plasmid. Note that most N2A cells are labeled.
B: Western blot corroboration of the decrease
in PrPc protein in N2A-transfected cell protein
extracts after the interference experiment. C–
F: Low power image of N2A cultures trans-
fected with siRNA(Prnp) (C,D) or siRNA(s-
crambled) (E,F) and treated with KA. Note
that siRNA(Prnp)-transfected cells showed in-
creased PI-uptake (C,D) in contrast to siR-
NA(scrambled)-N2A-transfected cells (E,F). G:
Histograms represent the mean 6 SD of three
independent experiments. *Statistical differen-
ces between columns (P < 0.05; ANOVA).
Scale bars: (A), 75 lm; (C), 100 lm pertains
to (D,E).
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ever, no detailed histologic correlation of KA-induced
seizures or AMPA-KA receptor expression analysis in
these mutant mice is available.
Our results corroborate that young adult Prnp 2/2
mice show increased sensitivity to KA-induced seizures
compared to wild-type mice under identical KA treat-
ments. This seizure sensitivity correlates with the well-
described pattern of neuronal degeneration in several brain
regions susceptible to KA (e.g., hippocampal region, amyg-
dala, or piriform cortex). We also show that neuronal
death correlates with enhanced activation of the stress-
associated kinases P38 and ERK1-2 in the KA-treated
hippocampi of PrPc-deﬁcient mice compared to wild-
type mice. Epileptic status rapidly induces the activation
of both kinases in the CA1-3 hippocampal ﬁelds (Jeon
et al., 2000; Ferrer et al., 2002). Interestingly, we cor-
roborate that the expression of these two kinases in Prnp
2/2 mice occurs in reactive astrocytes in the hippo-
Fig. 6. RNA expression of AMPA/KA receptors subunits in Prnp
2/2 and wild-type hippocampal tissue and after silencing of PrPc in
N2A cells. A: RT-PCR-ampliﬁed cDNAs of the GluR6 and GluR7
subunits and GAPDH from hippocampal extracts were mixed in a
single tube and electrophoretically separated in 4% acrylamide gels.
The ampliﬁed bands were identiﬁed on the basis of their size (right
site, e.g., 444 bp for GAPDH cDNA) and developed by Typhoon
8600 scanning. B: Densitometric quantiﬁcation of the AMPA/KA
subunit/GAPDH ratio of RNA expression from hippocampal extracts
in Prnp 2/2 (black bars) and wild-type (open bars) mice. *Statistical
differences between columns (P < 0.05; ANOVA). C,D: Agarose
gel (C) and parallel melting point experiment of the ampliﬁed prod-
ucts using the Sbgr real-time RT-PCR primers for GluR6, GluR7,
and GAPDH. The size of the ampliﬁed bands are identiﬁed on the
right side of (C). Note the presence of a single ampliﬁcation product
in (C) and the three independent curves in the melting point experi-
ment in (D), which indicate the efﬁciency of the ampliﬁed products
using the primers described. E: Histogram illustrating the quantitative
results of the real-time RT-PCR experiment of GluR6 and GluR7
mRNA levels in Prnp 2/2 (black bars) and wild-type (open bars)
hippocampi. F: Low power magniﬁcation illustrating the distribution
of GluR6-7 in Prnp 2/2 mouse hippocampus. Note the relevant
labeling of the pyramidal layer, and the dentate molecular layer and
the slm of the CA1-3. G: Histogram illustrating the quantitative
results of the real-time RT-PCR experiment of GluR6 and GluR7
mRNA levels in N2A cells after transfection with siRNA(Prnp)
(black bars) or siRNA(scramble) (open bars). Note the increased
expression of GluR6 and GluR7 after siRNA(Prnp) transfection.
Histograms in (E) and (G) represent the mean 6 SD of three
independent experiments. *Statistical differences between columns
(P < 0.05; ANOVA). Scale bar: (C), 500 lm; (D), 200 lm. Abbrevia-
tions: CA1-3, hippocampal ﬁelds; DG, dentate gyrus; GL, granular
layer; H, hilus; ML, molecular layer; SLM; stratum lacunosum-
moleculare; SO, stratum oriens; SP, stratum pyramidale, SR, stratum
radiatum. [Color ﬁgure can be viewed in the online issue, which is avail-
able at www.interscience.wiley.com.]
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campal CA1-3, as reported in control mice in other
studies (Che et al., 2001; Ferrer et al., 2002). In addi-
tion, a decrease in activated p38 was observed in dying
pyramidal cells in the CA1-3 region, which paralleled
increased JNK activation in these neurons.
Many studies have reported that the absence of
PrPc leads to a particular neuronal phenotype that is
sensitive to oxidative stress (Brown et al., 2002; Sakudo
et al., 2006). PrPc-deﬁcient mice show increased basal
levels of phospho-ERK1-2 as well as other intracellular
proteins (e.g., p53) or anti-apoptotic factors (e.g., bcl-2)
(Brown et al., 2002). Increased activation levels of P38
and ERK1-2 are involved in KA-induced seizure pre-
conditioning and ischemic tolerance (Gonzalez-Zulueta
et al., 2000; Jiang et al., 2005). This increased expression
of ERK1-2 in healthy untreated PrPc-deﬁcient mice
may explain the normal phenotype of Prnp 2/2 cells,
because sublethal activation of ERK1-2 and p38 might
protect neurons against the basal stress levels observed in
PrPc-deﬁcient neurons. Under conditions of increased
stress, however, such as those reported in the present
study (KA-injection), these palliative mechanisms cannot
further support neuron survival.
To date, ﬁve subunits of KA receptors have been
identiﬁed, GluR5, GluR6, GluR7, KA1, and KA2 (Holl-
mann and Heinemann, 1994; Lerma, 2006). GluR5-7
subunits display lower afﬁnity for KA than KA1-2 (Holl-
mann and Heinemann, 1994). However, GluR5-7 form
homomeric and heteromeric receptor channels, in contrast
to KA1-2, which assemble only heteromerically. We have
shown the expression of GluR6-7 in pyramidal neurons
of the hippocampal CA1-3. In addition, our RT-PCR
experiments show that endogenous mRNA levels of
GluR6 and GluR7 KA receptor subunits are increased in
the hippocampi of PrPc-deﬁcient mice compared to con-
trols. In addition, the silencing of PrPc production in neu-
roblastoma cells by siRNA leads to an increased expression
of GluR6 and GluR7. Several studies report the relevance
of GluR6 in susceptibility to KA. For example, lower lev-
els of susceptibility to this compound have been described
in mice devoid of GluR6 (Mulle et al., 1998). In addition,
the overexpression of GluR6 in rat hippocampal slices
induces seizures and spontaneous bursting (Telfeian et al.,
2000) whereas treatment with GluR6 antisense
oligonucleotides or speciﬁc peptides produces neuropro-
tective effects in the ischemic hippocampus (Pei et al.,
2005). These ﬁndings indicate that the susceptibility to
KA observed in Prnp 2/2 mice could be associated, at
least partially, with the increased levels of GluR6 and
GluR7 KA receptor subunits.
Whether PrPc participates in the modulation and
expression levels of KA receptor subunits is unknown.
However, many intracellular interactions have been
described for PrPc, including synaptic proteins (e.g.,
Synapsin I), adaptor proteins (Grb2), or cytoskeletal pro-
teins (PSD95/SAP90) (Sakudo et al., 2006). Although
the functions of most of these interactions are obscure,
most participate in cell survival and neurotransmission.
In addition, PrPc-induced intracellular transmission act-
ing via the Fyn and ERK1-2 intracellular cascade also
controls a large number of intracellular effectors and
neural functions (Chiarini et al., 2002; Monnet et al.,
2004; Gavin et al., 2005, which might, in turn, regulate
KA receptor expression or activity.
Moreover, our data also point to NMDA receptors
participating in the increased neurotoxicity in KA-treated
Prnp-deﬁcient neurons. In fact, the participation of
NMDA and non-NMDA receptors in KA-induced exci-
totoxicity has been described previously (Frandsen et al.,
1989) and facilitated glutamatergic transmission associated
with increased expression of N2RA and N2RB NMDA
receptor subunits has been reported in Prnp 2/2 mice
(Maglio et al., 2004). Decreased GABAa-mediated
inhibition has been also reported in PrPc-mutant mice
(Collinge et al., 1994) and it is well known that KA
decreases GABAergic inhibition in neurons (Lerma
2006). In conclusion, our results, together with those re-
ported above, indicate that factors involved in the onset
of epileptogenic processes are dysregulated in Prnp 2/2
mice and suggest that increased levels of GluR 6-7 may
participate in the susceptibility of Prnp 2/2 mice to
kainic acid.
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